- PRODUCT NAME:Pemetrexed Disodium Heptahydrate
Product Description: Pemetrexed Disodium Heptahydrate
Experience a breakthrough in cancer treatment with our Pemetrexed Disodium Heptahydrate – an advanced medication designed to target and combat certain types of cancer. This innovative compound is recognized for its effectiveness in inhibiting the growth of cancer cells and is used in the treatment of various malignancies.
Key Features:
1. Precision Cancer Treatment: Pemetrexed Disodium Heptahydrate belongs to a class of medications known as antifolate agents. It works by disrupting the production of crucial molecules required for cancer cell growth, ultimately inhibiting the spread of cancer within the body.
2. Broad Spectrum Usage: Our Pemetrexed Disodium Heptahydrate is approved for the treatment of several cancers, including non-small cell lung cancer (NSCLC), mesothelioma, and certain types of metastatic cancers. Its versatility in targeting multiple cancer types makes it a valuable tool in the fight against malignancies.
3. Combination Therapy: Pemetrexed Disodium Heptahydrate is often used in combination with other cancer treatments, such as platinum-based chemotherapy, to enhance its efficacy. This combination approach can lead to improved patient outcomes and better disease control.
4. Reduced Toxicity: Compared to some traditional chemotherapy agents, Pemetrexed Disodium Heptahydrate is known for its relatively lower toxicity profile. This can translate to fewer side effects and improved quality of life for patients undergoing treatment.
5. Comprehensive Dosing: Our Pemetrexed Disodium Heptahydrate is formulated to allow for accurate dosing based on individual patient characteristics, including body weight and overall health. This tailored dosing approach optimizes treatment outcomes while minimizing potential risks.
6. Expert Supervision: The use of Pemetrexed Disodium Heptahydrate should be closely monitored by a healthcare professional experienced in oncology. Regular medical assessments and laboratory tests are important to ensure the treatment's effectiveness and manage any potential side effects.
7. Empowering Patients: Our Pemetrexed Disodium Heptahydrate empowers patients with advanced treatment options, giving them hope and a chance to fight back against cancer with the support of cutting-edge medical science.
8. Ongoing Research: As a testament to its significance, Pemetrexed Disodium Heptahydrate continues to be the subject of clinical research and trials to explore its potential in treating various cancers. This dedication to research underscores its importance in modern oncology.
Harness the potential of Pemetrexed Disodium Heptahydrate in the battle against cancer. Embrace a treatment that's grounded in scientific innovation and has the potential to make a meaningful impact on your cancer journey. Prioritize your health and well-being with the power of Pemetrexed Disodium Heptahydrate today.
Note: This product description is provided for informational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting any cancer treatment or medication.
|
Test Items |
Specifications |
Result |
|
Appearance |
White or almost white powder |
White powder |
|
Identification |
(1) Retention time of the major peak in the chromatogram of assay corresponds to that in the chromatogram of the reference standard ・ |
Conforms |
|
(2) IR chromatogram corresponds to the chromatogram of the reference standard・ |
Conforms |
|
|
(3) Positive reaction of Sodium |
Conforms |
|
|
pH |
7・5〜8・4 |
8.1 |
|
Appearance of solution |
Not more opalescence than reference suspension II |
Conforms |
|
Not more intensely coloured than reference solution GY4 or Y4. |
Conforms |
|
|
Water |
19.5% 〜22.1% |
20.4% |
|
Related substances (HPLC) |
Impurity A≤0.15% |
0.05% |
|
Impurity D≤0.15% |
0.05% |
|
|
Any other impurity≤0.10% |
<0.05% |
|
|
Total impurities≤0.6% |
0.10% |
|
|
Enantiomeric purity (HPLC) |
ImpurityE≤0.3 % |
0.01% |
|
Assay |
Contain C2oHi9NsNa206 98.0%〜102.0%, as anhydrous substance. |
100.0% |
|
Bacterial Endotoxins |
<0.17EU/mg |
Conforms |
|
Additional Items (In-house) |
||
|
Specific rotation |
+10。~＋13。 |
+12° |
|
Heavy metals |
≤20ppm |
<20ppm |
|
Chloride |
≤0.1% |
<0.1% |
|
Residual Solvents (GC) |
Ethanol≤5000ppm |
0.0047% |
|
DMF≤880ppm |
ND |
|
|
Methylene Chloride≤600ppm |
ND |
|
|
Ethyl Acetate≤5000ppm |
ND |
|
|
Methanol≤3000ppm |
0.002% |
|
|
Trichloromethane≤60ppm |
ND |
|
|
* Benzene (skip) |
≤2ppm |
ND |
|
Total Aerobic microbial count |
≤1000CFU/g |
10CFU/g |
|
Total Yeast and Molds |
≤100CFU/g |
<10CFU/g |
|
Storage: Keep in a well-closed container, protected from light and stored at a temperature of 2°C to 8°C. |
||